Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy-Reference-Cited by-同舟云学术

Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy

Published:2012-07 Issue:4 Volume:11 Page:250-255
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Bittner Nathan,Merrick Gregory S.,Butler Wayne M.,Galbreath Robert W.,Lief Jonathan,Adamovich Edward,Wallner Kent E.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference27 articles.

1. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;J Am Med Assoc,1998

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Available at: http://www.nccn.org/professionals/physician_gls/about.asp. Accessed March 7, 2011.

3. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer;D’Amico;J Clin Oncol,2000

4. Clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer;D’Amico;Int J Radiat Oncol Biol Phys,2001

5. 15-Year biochemical relapse free survival in clinical T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience;Sylvester;Int J Radiat Oncol Biol Phys,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907);International Journal of Radiation Oncology*Biology*Physics;2024-02

2. A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer;Cancers;2021-08-24

3. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning;Brachytherapy;2019-05

4. Combined-modality 125J-seed-brachytherapy, external beam radiation and androgen deprivation therapy of unfavorable-risk prostate cancer: report of outcomes and side-effects;World Journal of Urology;2019-02-01

5. Treatment of patients with prostate cancer at high risk of its progression;Onkologiya. Zhurnal imeni P.A.Gertsena;2019